Explore comprehensive CDMO services offered by Takara Bio Inc, supporting end-to-end Drug Development and Manufacturing. Takara Bio Inc enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: China, Japan, U.S.A.
Description: Takara Bio operates as a CDMO (Contract Development and Manufacturing Organization) and a CMO (Contract Manufacturing Organization), providing a range of services that span the drug development and manufacturing pipeline, particularly for gene and cell therapies. While it offers both development and manufacturing through its CDMO services, its CMO services specifically focus on the manufacturing of products like viral vectors and mRNA. Takara Bio does not function as a CRO (Contract Research Organization) and does not provide clinical research services.
